NCT04891484View on ClinicalTrials.gov

Effect of Ondansetron on Spinal-induced Hypotension for Percutaneous Nephrolithotomy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

September 1, 2022

Conditions
Percutaneous Nephrolithotomy
Interventions
DRUG

Ondansetron group

patients will be injected with 4 mg Ondansetron diluted with normal saline IV 5 minutes before spinal anesthesia

DRUG

Saline group

patients will be injected with 10 ml normal saline intravenous 5 min before spinal anesthesia

Trial Locations (1)

050

Urology and nephrology center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT04891484 - Effect of Ondansetron on Spinal-induced Hypotension for Percutaneous Nephrolithotomy | Biotech Hunter | Biotech Hunter